The promises and challenges of plasmabased miRNA biomarkers Plasma samples as an ideal source of biomarkers:
• Plasma miRNAs show great promise as minimally invasive biomarkers for diverse pathological conditions • We have developed a versatile LNA™-based Universal RT-qPCR method for genome-wide profiling of miRNAs with absolute sensitivity, ease-of-use, that is optimal for clinical applications • An extensive QC and data analysis pipeline has been developed and implemented in order to facilitate large biomarker discovery and assay development studies • Full miRNA profiles were routinely generated from 35 µL of blood plasma in a clinical cohort consisting of 50 stage II CRC patients and 50 healthy controls • Preliminary classification suggests that early detection of CRC from plasma using miRNA PCR profiling is feasible Exiqon is the world leader in screening miRNA and is able to apply unique sample integrity QC checks such as checking any particular sample against a half a million PCR data point database profile to assess its overall performance
Exiqon is leading the development of effective normalization procedures that can be applied to clinical plasma or serum datasets
The PCR system has excellent sensitivity and specificity critical for accurate interpretation of small amounts of miRNA in 35 ul of plasma or serum . QC and data analysis pipeline. All raw data is submitted to filtering to remove technical errors, normalize the dataset, and reveal unforeseen technical and sample biases before data analysis. The pie chart shows an example of the pipeline applied to a set of 43 plasma samples profiled against 730 human miRNAs. . Supervised cluster analysis of the 50+50 CRC dataset using the most significant miRNAs (differentially expressed between classes as assessed by a two-sided t-test). . Schematic outline of the miRCURY LNA™ Universal RT microRNA PCR system. A polyA tail is added to the mature microRNA template (step 1a). cDNA is then synthesized using a PolyT primer with a 3' degenerate anchor and a 5' universal tag (step 1b). The cDNA template is then amplified using microRNA-specific and LNA™ enhanced forward and reverse primers (step 2a).SYBR ® Green is used for detection (step 2b).
Step 1: First-strand synthesis (RT)
Step 2: Real-time PCR amplification 
